Retirement of director / appointment of new director
NZX Code: ATM
ASX Code: A2M
The a2 Milk Company Limited
www.thea2milkcompany.com
13 May 2019
NZX/ASX Market Release
Retirement of independent non-executive director – Peter Hinton
Appointment of new independent non-executive director – Pip Greenwood
The a2 Milk Company Limited advises that Peter Hinton will be retiring from the Board at the end of the financial
year on 30 June, as foreshadowed at the Company’s 2018 Annual Meeting.
David Hearn, Chair of the Board, said of Peter’s retirement, “We would like to thank Peter for his exceptional and
longstanding commitment to the a2 Milk™ business, originally as advisor to and partner of Dr Corran McLachlan,
the Company’s founder, and subsequently as an adviser and director of the Company. We wish Peter all the best
as he pursues interests outside of The a2 Milk Company and corporate governance roles.”
The Company is pleased to advise that Pip Greenwood will be appointed as an independent non-executive
director of the Company with effect from 1 July 2019.
Pip is a director on the boards of Westpac New Zealand, Spark New Zealand and Fisher & Paykel Healthcare. She
was previously a senior partner at law firm Russell McVeagh, where she spent over ten years on the firm's board
including acting as the firm's board Chair and interim CEO. A leader in the field of corporate law and in the New
Zealand business community, Pip is also known for her work promoting greater diversity in the workplace. She is
the recipient of numerous industry awards including last year being named New Zealand Dealmaker of the Year at
the Australasian Law Awards 2018, the only person to have won this accolade five times, and has twice been
recognised as a finalist at the Women of Influence Awards.
David Hearn said of Pip’s appointment, “We are delighted to have a person of Pip’s considerable talent and
experience join the Board.”
The Board has determined that Ms Greenwood will be an independent director. A resolution to elect Ms
Greenwood will be put to shareholders at the Company’s next annual meeting in November 2019.
David Hearn
Chair
The a2 Milk Company Limited
For further information, please contact:
Investors / Analysts
David Akers
Head of Investor Relations
T +61 2 9697 7013 l M +61 412 944 577
david.akers@a2milk.com
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- NZX — NZX Limited: NZX board announces director appointment2019-06-25
“NZX Limited Level 1, NZX Centre 11 Cable Street PO Box 2959 Wellington 6140 New Zealand Tel +64 4 472 7599 www.nzx.com www.nzx.com 1 of 1 26 June 2019 NZX board announces director appointment The NZX board announces the appointment of John McMahon as a direct…”
- AFT — AFT Pharmaceuticals Limited: Annual Meeting and Closing Date for Director Nominations2019-06-03
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN 609 017 969 Market Release 4 June 2019 Annual Meeting and Closing Date for Director Nominations AFT Pharmaceuticals Limited (NZX: AFT, A…”
- GNZ — Goodman NZ: GMT Notice of Meeting2019-06-04
“E xplanator y notes Resolution 1: Re-appointment of Keith Smith Keith Smith retires by rotation at the meeting and offers himself for re-appointment. Keith is a professional director. He was previously a partner in the chartered accountancy practice of B…”